Search Results - "Zamora, M.R."

Pathologic Interpretation of Transbronchial Biopsy for Acute Rejection of Lung Allograft Is Highly Variable by Arcasoy, S. M., Berry, G., Marboe, C. C., Tazelaar, H. D., Zamora, M. R., Wolters, H. J., Fang, K. C., Keshavjee, S.

“…Despite the standardization of pathologic grading of acute rejection in transbronchial lung biopsies following lung transplantation, the reproducibility of…”
Get full text

Rhinovirus Infection in Adult Lung Transplant Recipients: A Case-Controlled Study by Vandervest, K.M, Zamora, M.R

“…Purpose Community acquired respiratory viruses (CARVs) occur frequently in lung transplant recipients (LTxRs). While Rhinovirus infection (RVI) is a commonly…”
Get full text

Cardiac Allograft Tolerance Induction via Anti-LFA-1 Monotherapy Is Dependent on an Indirect CD8 T-Cell by Plenter, R.J, Nelsen, M.K, Zamora, M.R, Gill, R.G, Pietra, B.A

Get full text

Analysis of a Modified Cytomegalovirus (CMV) Monitoring Algorithm for CMV Seropositive Lung Transplant Recipients by Schoeppler, K.E, Lyu, D.M, Crossno, J.T, Grazia, T.J, Vandervest, K.M, Zamora, M.R

Get full text

Everolimus for Calcineurin-Inhibitor Minimization in Lung Transplant Recipients With Chronic Renal Insufficiency: Four-Year Outcomes by Schoeppler, K.E, Lyu, D.M, Vandervest, K.M, Grazia, T.J, Crossno, J.T, Zamora, M.R

Get full text

A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings by Keshavjee, S., Davis, R.D., Zamora, M.R., de Perrot, M., Patterson, G.A.

“…Complement activation has been shown to play a significant role in ischemia-reperfusion injury after lung transplantation. TP-10 (soluble complement receptor 1…”
Get full text

The CYP3A Enzyme Inhibitor Diltiazem, Rather Than Genetic Polymorphisms, Is Associated with Everolimus Concentrations in Lung Transplant Recipients by Schoeppler, K.E, Aquilante, C.L, Kiser, T.H, Fish, D.N, Zamora, M.R

“…Purpose Everolimus (EVR) has a narrow therapeutic index and large inter-subject variability in pharmacokinetics (PK) following a fixed dose. EVR is a substrate…”
Get full text

Worldwide Survey of Paramyxoviridae Respiratory Infection Perceptions and Practices Among Adult Lung Transplant Centers by Ensor, C.R, Kwak, E.J, Merlo, C.A, Avery, R.K, Danziger-Isakov, L, Glanville, A.R, Nguyen, M.H, Orens, J.B, Pilewski, J.M, Potoski, B.A, Zamora, M.R, McDyer, J.F

Get full text

515 Everolimus for Calcineurin Inhibitor Minimization in Lung Transplant Recipients with Chronic Renal Insufficiency by Schoeppler, K, Lyu, D, Kim, I, Grazia, T, Crossno, J, Christians, U, Zamora, M.R

Get full text

172 Cyclosporine Inhalation Solution Does Not Improve Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplant: Results from the CYCLIST Trial by Johnson, B.A, Zamora, M.R, Budev, M.M, Kotloff, R.M, Iacono, A, Dilly, S.G, Verret, W.J, Golden, J.A

Get full text

241: Asymptomatic CMV viremia is associated with adverse outcomes following lung transplantation by Lyu, D.M, Nicolls, M, Zamora, M.R

Get full text

Use of cytomegalovirus immune globulin and ganciclovir for the prevention of cytomegalovirus disease in lung transplantation by Zamora, M.R.

“…Cytomegalovirus (CMV) infection and disease continue to be significant causes of morbidity and mortality in lung transplant recipients. The potential benefits…”
Get full text

41: Results of a Randomized Phase 2 Trial of ALN-RSV01, an RNAi Therapeutic, Lung Transplant (LTX) Patients Infected with Respiratory Syncytial Virus (RSV) by Zamora, M.R, Budev, M, Rolfe, M, Gottlieb, J, DeVincenzo, J, Cehelsky, J, Albert, G, Gollob, J, Nochur, S, Vaishnaw, A, Glanville, A

Get full text

137: Pre-transplant MICA, HLA class I or II antibodies are associated with earlier onset of bronchiolitis obliterans syndrome in lung transplant recipient by Lyu, D.M, Nicolls, M, Freed, B, Cagle, L, Zamora, M.R

Get full text

405: A Multicenter Prospective, Randomized, Placebo-Controlled Trial of a CXCL8 Inhibitor (Reparixin) To Prevent Primary Graft Dysfunction after Lung Transplantation by Meyers, B.F, Keshavjee, S, Zamora, M.R, Davis, R.D, Smith, M.A, McFadden, P.M, Hertz, M.I, Daffonchio, L, Novellini, R

Get full text

421: Effect of induction therapy on the peripheral blood genomic signature in the LARGO lung transplant study by Keshavjee, S, McCurry, K.R, Davis, R.D, Pilewski, J.M, Corris, P.A, Zeevi, A, Waddell, T.K, Arcasoy, S.M, Golden, J.G, Strueber, M, Doyle, R.L, Jaksch, P, Mehta, A.C, Mulligan, M.S, Pajaro, O.E, Zamora, M.R, Sweet, S, Woodward, R.N, Dedrick, R.D, Wolters, H, Fang, K.C, Trulock, E.P

Get full text

351: Refining the identification of discriminatory genes for rejection in lung transplantation: The LARGO Study by Keshavjee, S, Berry, G, Marboe, C.C, Wilt, J.S, Trulock, E.P, Corris, P.A, Doyle, R.L, McCurry, K.R, Arcasoy, S.M, Davis, R.D, Golden, J.G, Strueber, M, Sweet, S, Jaksch, P, Mehta, A.C, Mulligan, M.S, Pajaro, O.E, Sun, J.T, Klingler, T.M, Rosenberg, S, Dedrick, R.D, Wolters, H, Fang, K.C, Zamora, M.R

Get full text

Lung Quality and Utilization in Controlled Donation After Circulatory Determination of Death Within the United States by Mooney, J. J., Hedlin, H., Mohabir, P. K., Vazquez, R., Nguyen, J., Ha, R., Chiu, P., Patel, K., Zamora, M. R., Weill, D., Nicolls, M. R., Dhillon, G. S.

“…Although controlled donation after circulatory determination of death (cDCDD) could increase the supply of donor lungs within the United States, the yield of…”
Get full text

Increasing Lung Allocation Scores Predict Worsened Survival Among Lung Transplant Recipients by Liu, V., Zamora, M. R., Dhillon, G. S., Weill, D.

“…Implemented in 2005, the lung allocation score (LAS) aims to distribute donor organs based on overall survival benefits for all potential recipients, rather…”
Get full text

C-Kit-Derived CD11b+ Cells are Critical for Cardiac Allograft Prolongation by Autologous C-Kit+ Progenitor Cells by Grazia, T.J., Plenter, R.J., Coulombe, M.G., Lin, C.M., Gill, R.G., Zamora, M.R.

“…Published results show that autologous C-Kit+ cells robustly prolong cardiac allografts in a C-Kit and dose-dependent fashion. To extend our understanding, we…”
Get full text